Submit a Response to This Article
Jump to comment:
- Clarification: Use of meperidineShow More
Congratulations to the authors for a clear and concise article. The tables are very helpful.
With regard to the use of meperidine in CNCP, while the risk of seizures is noted with parenteral meperidine, it is increased several fold by the use of oral meperidine. given orally, the molecule undergoes hepatic metabolism to normeperidine, which also accumulates in the face of renal failure. Seizures can occur followi...
Competing Interests: None declared.
In this issue
Canadian guideline for safe and effective use of opioids for chronic noncancer pain
Jump to section
Related Articles
Cited By...
- Opioid stewardship: implementing a proactive, pharmacist-led intervention for patients coprescribed opioids and benzodiazepines at an urban academic primary care centre
- Opioid prescribing is a surrogate for inadequate pain management resources
- La prescription dopioides: un substitut au manque de ressources en controle de la douleur
- Prescrire du cannabis fume pour la douleur chronique non cancereuse: Recommandations preliminaires
- Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations
- Tramadol
- Searching for hope
- Canadian guideline for safe and effective use of opioids for chronic noncancer pain: Clinical summary for family physicians. Part 2: special populations